Titan Biotech Ltd has informed BSE that in addition to the Audited Financial Results for the F.Y. ended as on March 31, 2018, the Board of Director will also consider recommending of dividend on equity shares of the company in the board meeting scheduled on May 29, 2018.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
